Max Healthcare Institute Limited
Simbols: MAXHEALTH.NS
NSE
734.85
INRTirgus cena šodien
73.1982
P/E koeficients
0.1485
PEG koeficients
714.17B
MRK Cap
- 0.00%
DIV ienesīgums
Max Healthcare Institute Limited (MAXHEALTH-NS) Finanšu pārskati
Bilance
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 14986.1 | 4864.2 | 6267.9 | ||||||||||
balance-sheet.row.short-term-investments | 0 | 14558.6 | 1772.8 | 2 | ||||||||||
balance-sheet.row.net-receivables | 0 | 3519 | 4309.3 | 4259.7 | ||||||||||
balance-sheet.row.inventory | 0 | 762.3 | 613.6 | 538 | ||||||||||
balance-sheet.row.other-current-assets | 0 | 163.3 | 215.8 | 179.1 | ||||||||||
balance-sheet.row.total-current-assets | 0 | 19430.7 | 10002.9 | 11244.7 | ||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 22256.3 | 20583.2 | 17749.1 | ||||||||||
balance-sheet.row.goodwill | 0 | 24546.6 | 24546.6 | 24546.6 | ||||||||||
balance-sheet.row.intangible-assets | 0 | 26108.4 | 26557.3 | 23337.4 | ||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 50655 | 51103.9 | 47884 | ||||||||||
balance-sheet.row.long-term-investments | 0 | 5.1 | 20.2 | 10.4 | ||||||||||
balance-sheet.row.tax-assets | 0 | 5430.4 | 10181.2 | 9.8 | ||||||||||
balance-sheet.row.other-non-current-assets | 0 | 3241 | -0.1 | 8546.4 | ||||||||||
balance-sheet.row.total-non-current-assets | 0 | 81587.8 | 81888.4 | 74199.7 | ||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-assets | 0 | 101018.5 | 91891.3 | 85444.4 | ||||||||||
balance-sheet.row.account-payables | 0 | 5434.6 | 4520.8 | 4356.9 | ||||||||||
balance-sheet.row.short-term-debt | 0 | 845 | 1138 | 877.4 | ||||||||||
balance-sheet.row.tax-payables | 0 | 26.8 | 0 | 0.5 | ||||||||||
balance-sheet.row.long-term-debt-total | 0 | 6044.6 | 10188.7 | 12375.2 | ||||||||||
Deferred Revenue Non Current | 0 | 117.3 | 108.2 | 114.1 | ||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||
balance-sheet.row.other-current-liab | 0 | 846.8 | 725.5 | 654 | ||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 16466.9 | 21493.9 | 21288.3 | ||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 1241.4 | 4060.2 | 4063 | ||||||||||
balance-sheet.row.total-liab | 0 | 26922.6 | 29066.6 | 29057.6 | ||||||||||
balance-sheet.row.preferred-stock | 0 | 73630.6 | 0 | 56121.7 | ||||||||||
balance-sheet.row.common-stock | 0 | 9709.2 | 9696.1 | 9659.5 | ||||||||||
balance-sheet.row.retained-earnings | 0 | 12340.6 | 1476.1 | -4585.9 | ||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 465.3 | 275.5 | 265.1 | ||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -22049.8 | 51377 | -5073.6 | ||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 74095.9 | 62824.7 | 56386.8 | ||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 101018.5 | 91891.3 | 85444.4 | ||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-equity | 0 | 74095.9 | 62824.7 | 56386.8 | ||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||
Total Investments | 0 | 2065.4 | 20.2 | 10.4 | ||||||||||
balance-sheet.row.total-debt | 0 | 6889.6 | 11326.7 | 13252.6 | ||||||||||
balance-sheet.row.net-debt | 0 | 6462.1 | 8235.3 | 6986.7 |
Naudas plūsmas pārskats
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 10637.2 | 7389 | -686.5 | ||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 2321.9 | 2211.2 | 1740.9 | ||||||||||
cash-flows.row.deferred-income-tax | 0 | -1789 | -1469.1 | 549.9 | ||||||||||
cash-flows.row.stock-based-compensation | 0 | 343.5 | 339.3 | 265.1 | ||||||||||
cash-flows.row.change-in-working-capital | 0 | 806.4 | -1319.6 | -3762.5 | ||||||||||
cash-flows.row.account-receivables | 0 | 647.4 | 29.1 | 560.6 | ||||||||||
cash-flows.row.inventory | 0 | -148.7 | -75.6 | 172.5 | ||||||||||
cash-flows.row.account-payables | 0 | 987.4 | -447.8 | -4779 | ||||||||||
cash-flows.row.other-working-capital | 0 | -679.7 | -825.3 | 283.4 | ||||||||||
cash-flows.row.other-non-cash-items | 0 | -228.2 | 334.1 | 3071.7 | ||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -3356.1 | -5613.1 | -1184.2 | ||||||||||
cash-flows.row.acquisitions-net | 0 | -4.8 | -1071.6 | 16.2 | ||||||||||
cash-flows.row.purchases-of-investments | 0 | -10757.7 | -1711.9 | 0 | ||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 997.1 | 2783.5 | 0 | ||||||||||
cash-flows.row.other-investing-activites | 0 | 1251.4 | -2104.6 | 438 | ||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -11870.1 | -7717.7 | -730 | ||||||||||
cash-flows.row.debt-repayment | 0 | -1398.8 | -2496 | -8326.3 | ||||||||||
cash-flows.row.common-stock-issued | 0 | 13.1 | 36.6 | 11791.6 | ||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.other-financing-activites | 0 | -1499.9 | -482.3 | -1552 | ||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -2885.6 | -2941.7 | 1913.3 | ||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 2793.9 | ||||||||||
cash-flows.row.net-change-in-cash | 0 | -2663.9 | -3174.5 | 5155.8 | ||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 427.5 | 3091.4 | 6265.9 | ||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 3091.4 | 6265.9 | 1110.1 | ||||||||||
cash-flows.row.operating-cash-flow | 0 | 12091.8 | 7484.9 | 1178.6 | ||||||||||
cash-flows.row.capital-expenditure | 0 | -3356.1 | -5613.1 | -1184.2 | ||||||||||
cash-flows.row.free-cash-flow | 0 | 8735.7 | 1871.8 | -5.6 |
Peļņas vai zaudējumu aprēķina rinda
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 45626 | 38831.9 | 24824.1 | ||||||||||
income-statement-row.row.cost-of-revenue | 0 | 9220.1 | 9229 | 5944.1 | ||||||||||
income-statement-row.row.gross-profit | 0 | 36405.9 | 29602.9 | 18880 | ||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.other-expenses | 0 | 268.6 | 109.6 | 100 | ||||||||||
income-statement-row.row.operating-expenses | 0 | 26322.5 | 21848.4 | 16040.8 | ||||||||||
income-statement-row.row.cost-and-expenses | 0 | 35542.6 | 31077.4 | 21984.9 | ||||||||||
income-statement-row.row.interest-income | 0 | 1123.8 | 750.9 | 767.3 | ||||||||||
income-statement-row.row.interest-expense | 0 | 838.6 | 900.1 | 1710 | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 397 | -190.6 | -3347.5 | ||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.other-operating-expenses | 0 | 268.6 | 109.6 | 100 | ||||||||||
income-statement-row.row.total-operating-expenses | 0 | 397 | -190.6 | -3347.5 | ||||||||||
income-statement-row.row.interest-expense | 0 | 838.6 | 900.1 | 1710 | ||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 2321.9 | 2211.2 | 1740.9 | ||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.operating-income | 0 | 10240.2 | 7579.6 | 2430.5 | ||||||||||
income-statement-row.row.income-before-tax | 0 | 10637.2 | 7389 | -686.5 | ||||||||||
income-statement-row.row.income-tax-expense | 0 | -397.9 | 1338.5 | 458.5 | ||||||||||
income-statement-row.row.net-income | 0 | 11035.1 | 6050.5 | -1375.5 |
Biežāk uzdotie jautājumi
Kas ir Max Healthcare Institute Limited (MAXHEALTH.NS) kopējie aktīvi?
Max Healthcare Institute Limited (MAXHEALTH.NS) kopējie aktīvi ir 101018500000.000.
Kādi ir uzņēmuma gada ieņēmumi?
Gada ieņēmumi ir N/A.
Kāda ir uzņēmuma peļņas norma?
Uzņēmuma peļņas norma ir 0.833.
Kāda ir uzņēmuma brīvā naudas plūsma?
Brīvā naudas plūsma ir 3.948.
Kāda ir uzņēmuma neto peļņas norma?
Neto peļņas norma ir 0.203.
Kādi ir uzņēmuma kopējie ieņēmumi?
Kopējie ieņēmumi ir 0.259.
Kāda ir Max Healthcare Institute Limited (MAXHEALTH.NS) tīrā peļņa (tīrie ienākumi)?
Tīrā peļņa (tīrie ienākumi) ir 11035100000.000.
Kāds ir uzņēmuma kopējais parāds?
Kopējais parāds ir 6889600000.000.
Kāds ir pamatdarbības izdevumu skaits?
Darbības izdevumi ir 26322500000.000.
Kāds ir uzņēmuma skaidrās naudas rādītājs?
Uzņēmuma nauda ir 0.000.